-
Mashup Score: 0Genomic biomarkers in metastatic colorectal cancer - 2 month(s) ago
John Strickler, MD Duke Cancer Center, Durham, NC Kristen Ciombor, MD, MSCI Vanderbilt-Ingram Cancer Center, Nashville, TN Yoshiaki Nakamura, MD, PhD, National Cancer Center Hospital East, Kashiwa, Japan Benedikt Westphalen, MD LMU Hospital, Munich, Germany Sebastian Stintzing, MD Charite University Hospital, Berlin, Germany Filippo Pietrantonio, MD Istituto Nazionale dei Tumori, Milan, Italy Several genetic alterations play a role in the pathogenesis of mCRC, and testing of these biomarkers is an
Source: www.vjoncology.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Genomic biomarkers in metastatic colorectal cancer - 6 month(s) ago
John Strickler, MD Duke Cancer Center, Durham, NC Kristen Ciombor, MD, MSCI Vanderbilt-Ingram Cancer Center, Nashville, TN Yoshiaki Nakamura, MD, PhD, National Cancer Center Hospital East, Kashiwa, Japan Benedikt Westphalen, MD LMU Hospital, Munich, Germany Sebastian Stintzing, MD Charite University Hospital, Berlin, Germany Filippo Pietrantonio, MD Istituto Nazionale dei Tumori, Milan, Italy Several genetic alterations play a role in the pathogenesis of mCRC, and testing of these biomarkers is an
Source: www.vjoncology.comCategories: General Medicine News, Onc News and JournalsTweet
John H. Strickler, Duke Cancer Center updates us on data from the #MOUNTAINEER, and the impact of #HER2 levels on response rate in #mCRC 🎥 Explore our feature to find out more about the importance of #genomic #biomarkers in #mCRC 🗞️ 👉 https://t.co/ItCZUJRQrn #Oncology #CRCsm